Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis

NCT07192939 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

IPF and PPF

Interventions

DRUG: HRS-9813 capsules
DRUG: HRS-9813 capsules
DRUG: HRS-9813 capsule mimetic

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd